
med.21724, Compound Benztropine
Benzatropine is tropane in which a hydrogen at position 3 is substituted by a diphenylmethoxy group (endo-isomer). An acetylcholine receptor antagonist, it is used (particularly as its methanesulphonate salt) in the treatment of Parkinson's disease, and to reduce parkinsonism and akathisia side effects of antipsychotic treatments. It has a role as a oneirogen, an antiparkinson drug, a muscarinic antagonist, a parasympatholytic and an antidyskinesia agent. — ChEBI
- IUPAC name
- (1R,5S)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane
- Molecular formula
- C21H25NO
- Molecular weight
- 307.4 g/mol
- Exact mass
- 307.193614421 Da
- XLogP3
- 4.5
- Topological polar surface area
- 12.5 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 2
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:3048
- ChEBI:CHEBI:94707
- ChEMBL:CHEMBL1201203
- ChEMBL:CHEMBL1618180
- ChEMBL:CHEMBL438151
- EPA DTXSID:DTXSID9022659
- PubMed:34326460
- PubMed:28176326
- PubMed:25973388
- PubMed:25548026
- PubMed:24709263
- PubMed:20142494
- PubMed:17897630
- PubMed:16134091
- PubMed:12966155
- PubMed:11978145
- PubMed:10952768
- PubMed:7562926
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.